Immunotherapy Effective Against Neuroblastoma In Children
Wednesday, May 20, 2009 - 20:35
in Health & Medicine
A phase III study has shown that adding an antibody-based therapy that harnesses the body's immune system resulted in a 20 percent increase in the number of children living disease-free for at least two years with neuroblastoma. Neuroblastoma, a hard-to-treat cancer arising from nervous system cells, is responsible for 15 percent of cancer-related deaths in children.